GLP-1

Ascletis sees no benefit to high, fast oral GLP-1 dose titration

The latest results show a high starting dose, fast titration model provides the same weight loss and worse tolerability than more measured approaches.

Nick Paul Taylor Apr 23, 2025 7:25am

Ypsomed sells diabetes business to focus on GLP-1 self-injectors

Apr 23, 2025 6:20am

Lilly's oral GLP-1 delivers Ozempic-like efficacy in phase 3

Apr 17, 2025 6:45am

Pfizer axes oral GLP-1 asset, blowing hole in obesity plan

Apr 14, 2025 7:34am

R&D cost per drug up year over year: Deloitte

Mar 25, 2025 12:01am

Novo pens $2B deal for triple agonist weight loss drug

Mar 24, 2025 9:50am